BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merzon E, Green I, Shpigelman M, Vinker S, Raz I, Golan-Cohen A, Eldor R. Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes. Diabetes Metab Res Rev 2021;37:e3398. [PMID: 32852883 DOI: 10.1002/dmrr.3398] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Novida H, Soelistyo SA, Cahyani C, Siagian N, Hadi U, Pranoto A. Factors associated with disease severity of COVID‑19 in patients with type 2 diabetes mellitus. Biomed Rep 2023;18:8. [PMID: 36570802 DOI: 10.3892/br.2022.1590] [Reference Citation Analysis]
2 Green I, Merzon E, Vinker S, Golan-cohen A, Israel A, Scheinowitz M, Ishai R, Ashkenazi S, Magen E. A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection. European Journal of General Practice 2022. [DOI: 10.1080/13814788.2022.2138855] [Reference Citation Analysis]
3 Abou-Ghaida J, Foster A, Klein S, Bassie M, Gu K, Hille C, Brown C, Daniel M, Drakeley C, Jahnke A, Karim A, Altabbakh O, Phillpotts L. The World-Wide Adaptations of Diabetic Management in the Face of COVID-19 and Socioeconomic Disparities: A Scoping Review. Cureus 2022;14:e31911. [PMID: 36579222 DOI: 10.7759/cureus.31911] [Reference Citation Analysis]
4 Bhagat A, Buxton L, Hasan M. Correlation Between HbA1c Levels and Mortality Rates in Hospitalized COVID-19 Patients. Cureus 2022. [DOI: 10.7759/cureus.31347] [Reference Citation Analysis]
5 Sherwani S, Raafat M, Rajendrasozhan S, Khan M, Saleem M, Husain Q, Khan S, Alam N, Khan MWA. Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD). CIMB 2022;44:5260-5276. [DOI: 10.3390/cimb44110358] [Reference Citation Analysis]
6 Fukushima T, Chubachi S, Namkoong H, Asakura T, Tanaka H, Lee H, Azekawa S, Okada Y, Koike R, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 task force. Diabetes Obes Metab 2023;25:144-55. [PMID: 36056760 DOI: 10.1111/dom.14857] [Reference Citation Analysis]
7 Jackson SL, Block JP, Rolka DB, Pavkov ME, Chevinsky JR, Lekiachvili A, Carton TW, Thacker D, Denson JL, Paranjape A, Kappelman MD, Boehmer TK, Twentyman E. COVID-19 Outcomes Stratified by Control Status of Hypertension and Diabetes: Preliminary Findings From PCORnet, U.S. AJPM Focus 2022;1:100012. [DOI: 10.1016/j.focus.2022.100012] [Reference Citation Analysis]
8 Dandachi I, Aljabr W. Prognosis of COVID-19 in the middle eastern population, knowns and unknowns. Front Microbiol 2022;13:974205. [DOI: 10.3389/fmicb.2022.974205] [Reference Citation Analysis]
9 Yanamandra U, Rajagopal S, Aggarwal B, Kaur P, Singh A, Aggarwal N, Sai Kumar PB, Duhan G, Sahu R, Menon A. Sweetness and positivity together aren't a happy ending: Case controlled study amongst severe COVID-19 for impact of diabetes mellitus on survival. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.06.010] [Reference Citation Analysis]
10 Cho WKT, Hwang DG. Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area. J Racial and Ethnic Health Disparities. [DOI: 10.1007/s40615-022-01351-1] [Reference Citation Analysis]
11 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
12 Niraula A, Baral N, Lamsal M, Bataju M, Thapa S. Potential role of biochemical markers in the prognosis of COVID-19 patients. SAGE Open Med 2022;10:20503121221108613. [PMID: 35832258 DOI: 10.1177/20503121221108613] [Reference Citation Analysis]
13 Robeva R, Petrova D, Elenkova A, Tankova T, Zacharieva S. C-peptide levels and glycemic indices in COVID-19 patients. Biotechnology & Biotechnological Equipment 2022;36:418-424. [DOI: 10.1080/13102818.2022.2090858] [Reference Citation Analysis]
14 Yeh HC, Kraschnewski JL, Kong L, Lehman EB, Heilbrunn ES, Williams P, Poger JM, Francis E, Bryce CL. Hospitalization and mortality in patients with COVID-19 with or at risk of type 2 diabetes: data from five health systems in Pennsylvania and Maryland. BMJ Open Diabetes Res Care 2022;10:e002774. [PMID: 35680172 DOI: 10.1136/bmjdrc-2022-002774] [Reference Citation Analysis]
15 Zhang J, Zhang J, Tao Z. Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2. Front Endocrinol 2022;13:861443. [DOI: 10.3389/fendo.2022.861443] [Reference Citation Analysis]
16 Cummings C, Seng K, Tweet R, Wagner J. Lifestyles Under Lockdown: A Scoping Review of International Studies on Type 2 Diabetes Self-Management Behaviors During COVID-19. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.830353] [Reference Citation Analysis]
17 Meyer AA, Mathews EH, Gous AGS, Mathews MJ. Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications. Front Cardiovasc Med 2022;9:737592. [DOI: 10.3389/fcvm.2022.737592] [Reference Citation Analysis]
18 Datta BK, Ansa BE, George V. An analytical model of population level chronic conditions and COVID-19 related hospitalization in the United States. BMC Public Health 2022;22:208. [PMID: 35101029 DOI: 10.1186/s12889-022-12531-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Merzon E, Green I, Somekh E, Vinker S, Golan-Cohen A, Israel A, Gorohovski A, Frenkel-Morgenstern M, Stein M. The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study. Vaccines (Basel) 2022;10:74. [PMID: 35062735 DOI: 10.3390/vaccines10010074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Guo L. Peer Review of “COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis”. JMIRx Med 2021;2:e35517. [DOI: 10.2196/35517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Lee M, Sallah YH, Petrone M, Ringer M, Cosentino D, Vogels CBF, Fauver JR, Alpert TD, Grubaugh ND, Gupta S. Authors' Response to Peer Reviews of “COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis”. JMIRx Med 2021;2:e35515. [DOI: 10.2196/35515] [Reference Citation Analysis]
22 Lee M, Sallah YH, Petrone M, Ringer M, Cosentino D, Vogels CBF, Fauver JR, Alpert TD, Grubaugh ND, Gupta S. COVID-19 Outcomes and Genomic Characterization of SARS-CoV-2 Isolated From Veterans in New England States: Retrospective Analysis. JMIRx Med 2021;2:e31503. [PMID: 35014989 DOI: 10.2196/31503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Sandhu AT, Kohsaka S, Lin S, Woo CY, Goldstein MK, Heidenreich PA. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system. Am Heart J 2021;240:46-57. [PMID: 34126079 DOI: 10.1016/j.ahj.2021.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
25 Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, Barenholz-Goultschin O, Stokar J. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study. PLoS One 2021;16:e0254847. [PMID: 34293038 DOI: 10.1371/journal.pone.0254847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Windham S, Wilson MP, Fling C, Sheneman D, Wand T, Babcock L, MaWhinney S, Erlandson KM. Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis. Ther Adv Infect Dis 2021;8:20499361211027390. [PMID: 34249357 DOI: 10.1177/20499361211027390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Whyte MB, Vas PRJ, Umpleby AM. Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19? Front Endocrinol (Lausanne) 2021;12:649405. [PMID: 34220705 DOI: 10.3389/fendo.2021.649405] [Reference Citation Analysis]
28 Sánchez Díaz JS, Peniche Moguel KG, González Escudero EA, Del Carpio Orantes L, Monares Zepeda E, Perez Nieto OR, Zamarron Lopez EI, Deloya Tomas E, Estrada Gonzalez FE, Díaz Torres J, Escarraman Martinez D, Guerrero Gutierrez MA. Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19. Expert Rev Respir Med 2021;15:1077-82. [PMID: 33955309 DOI: 10.1080/17476348.2021.1926988] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Lin CL, Huang LC, Chang YT, Chen RY, Yang SH. Under COVID-19 Pandemic: A Quasi-Experimental Trial of Observation on Diabetes Patients' Health Behavior Affected by the Pandemic From a Coaching Intervention Program. Front Public Health 2021;9:580032. [PMID: 34055704 DOI: 10.3389/fpubh.2021.580032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta P, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann A, Markram H. Elevated Blood Glucose Levels as a Primary Risk Factor for the Severity of COVID-19.. [DOI: 10.1101/2021.04.29.21256294] [Reference Citation Analysis]
31 Longmore DK, Miller JE, Bekkering S, Saner C, Mifsud E, Zhu Y, Saffery R, Nichol A, Colditz G, Short KR, Burgner DP; International BMI-COVID consortium., *International BMI-COVID consortium. Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis. Diabetes Care 2021:dc202676. [PMID: 33858854 DOI: 10.2337/dc20-2676] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
32 Bukva M, Islamović M, Jusufović S, Njemčević E, Meseldžić N, Bego T. The Most Significant Biomarkers and Specific Antibodies for the Early Diagnosis and Monitoring in COVID-19 Patients. IFMBE Proceedings 2021. [DOI: 10.1007/978-3-030-73909-6_95] [Reference Citation Analysis]
33 Barone MTU, Ngongo B, Harnik SB, Oliveira LX, Végh D, de Luca PV, Pedrosa HC, Giraudo F, Cardona-Hernandez R, Chaudhury N, Menna-Barreto L. COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis. Diabetes Res Clin Pract 2021;171:108587. [PMID: 33307134 DOI: 10.1016/j.diabres.2020.108587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
34 Jankovic I, Basina M. Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients. J Diabetes Sci Technol 2021;15:174-6. [PMID: 33084380 DOI: 10.1177/1932296820965203] [Reference Citation Analysis]